Written and maintained by CASRAI Editorial Board
Published · Last updated
On this page
Short answer: the bile solubility test checks whether a streptococcal isolate is dissolved by bile salts (sodium deoxycholate). Pneumococci (Streptococcus pneumoniae) lyse, so a clearing tube or a flattened colony counts as a positive result, while bile-resistant streptococci are unaffected. It is rarely read alone: the CDC meningitis laboratory manual pairs it with optochin susceptibility.
General laboratory information only, not medical advice and not a procedure. Follow your laboratory’s validated method and the reagent manufacturer’s instructions.
Definition and scope
Bile solubility is a phenotypic test used on alpha-hemolytic streptococci. Bile salts trigger lysis of pneumococci, so the cell suspension or colony visibly disappears, and the test reads that loss. It identifies a behaviour, not a species name, which is why the sections below spend as much time on what a result does not prove as on what it shows.
The reagents and media used for this kind of work fall under the FDA device category “microorganism differentiation and identification device” in 21 CFR 866.2660: a device intended for medical purposes, made of components such as differential culture media and biochemical reagents, used to differentiate and identify selected microorganisms. The regulation classifies it as Class I (general controls) and exempts it from premarket notification (checked 2026-10-30, Cornell LII copy of the CFR).
How it works in practice
The CDC manual (August 1998 edition; check current laboratory guidance) describes two formats, which differ in how the reagent is applied and read:
| Format | Reagent named by CDC | What counts as positive |
|---|---|---|
| Tube | 2% deoxycholate (bile salts) added to a saline suspension of the isolate, read against a saline control tube | Clearing of the tube or loss of turbidity |
| Plate (colony spot) | A drop of 10% sodium deoxycholate placed directly on a colony | Pneumococcal colonies disappear or are flattened; bile-resistant colonies are unaffected |
The manual stresses that a freshly prepared plate is essential for the plate format. Because the stated reagent strength differs by format (2% in the tube, 10% for the colony spot), a laboratory should confirm which format its method uses.
Bile solubility next to optochin: a decision aid
The CDC manual places it after optochin susceptibility (a 6 mm disk with 5 µg ethylhydrocupreine) and uses it to settle the middle ground:
| Optochin result (CDC manual) | Role of bile solubility | Conclusion stated by CDC |
|---|---|---|
| Zone of 14 mm or more | Not needed to call it | Pneumococcus |
| Smaller but definite zone (alpha-hemolytic isolates with zones of 9-13 mm should be tested) | Decides the call | Bile soluble: pneumococcus. Not bile soluble: not a pneumococcus |
| No zone | Not needed | Not a pneumococcus |
Esculin hydrolysis is a different test
“Esculin hydrolysis test” is often searched alongside bile solubility, but it is a separate reaction read on separate media. It is covered in the guide to the bile esculin agar test. For where both tests sit among other biochemical steps, see identifying bacteria in the laboratory; for the staining step that usually comes first, see S. pneumoniae Gram stain. Bile salts also appear as a selective ingredient in some media, such as XLD agar, which is a use of deoxycholate unrelated to lysis of pneumococci.
Where it matters for labs and supply decisions
- Reagent category: deoxycholate reagents and identification media sit under 21 CFR 866.2660 (Class I, 510(k)-exempt), so regulatory status alone does not distinguish one reagent from another.
- Format drives the reagent: the tube and plate formats use different stated strengths per CDC, so a laboratory sources reagent for the format it validated.
- Freshness of cultures: the manual requires a freshly prepared plate for the colony spot format.
- Validation: a peer-reviewed study recommends that each laboratory validate any cut-off against its own verified strains (below).
Common misunderstandings
“A positive result proves S. pneumoniae”
Not on its own. A 2017 Scientific Reports study of 84 isolates found the conventional test generally accurate but difficult to interpret because it rests on subjective human evaluation. In its spectrophotometric version, one S. mitis isolate exceeded the study cut-off, and S. mitis strains with unusually high readings carried the autolysin gene. S. pseudopneumoniae isolates gave intermediate values. The authors describe the data on this as very limited, and the study was small (only 9 S. pseudopneumoniae isolates), so treat it as a caution, not a rule.
“Bile solubility and bile esculin are the same thing”
They are different tests with different readouts; see the esculin section above.
“The test replaces optochin”
In the CDC scheme the two are complementary: optochin first, bile solubility for the borderline zones.
FAQ
What is a positive bile solubility test?
Per the CDC manual, clearing or loss of turbidity in the tube, or colonies that disappear or flatten on the plate, with bile-resistant colonies unaffected. The reading is visual and subjective.
Is esculin hydrolysis part of the bile solubility test?
No. Esculin hydrolysis is a separate test; see the bile esculin agar test guide linked above.
Which reagent is used?
The CDC manual names 2% deoxycholate (bile salts) for the tube format and 10% sodium deoxycholate for the colony spot format.
Sources
- CDC, Laboratory Methods for the Diagnosis of Meningitis Caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae, 1998 edition, sections on optochin susceptibility and bile solubility: stacks.cdc.gov/view/cdc/28557 (checked 2026-10-30).
- Slotved HC, Facklam RR, Fuursted K. Sci Rep 2017;7:7167, doi:10.1038/s41598-017-07772-x: PMC5540920 (checked 2026-10-30).
- 21 CFR 866.2660, microorganism differentiation and identification device: law.cornell.edu/cfr/text/21/866.2660 (checked 2026-10-30).







